Publication: Identification of human CCR8 as a CCL18 receptor
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Rockefeller University Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Islam, Sabina A., Morris F. Ling, John Leung, Wayne G. Shreffler, and Andrew D. Luster. 2013. “Identification of human CCR8 as a CCL18 receptor.” The Journal of Experimental Medicine 210 (10): 1889-1898. doi:10.1084/jem.20130240. http://dx.doi.org/10.1084/jem.20130240.
Research Data
Abstract
The CC chemokine ligand 18 (CCL18) is one of the most highly expressed chemokines in human chronic inflammatory diseases. An appreciation of the role of CCL18 in these diseases has been hampered by the lack of an identified chemokine receptor. We report that the human chemokine receptor CCR8 is a CCL18 receptor. CCL18 induced chemotaxis and calcium flux of human CCR8-transfected cells. CCL18 bound with high affinity to CCR8 and induced its internalization. Human CCL1, the known endogenous CCR8 ligand, and CCL18 competed for binding to CCR8-transfected cells. Further, CCL1 and CCL18 induced heterologous cross-desensitization of CCR8-transfected cells and human Th2 cells. CCL18 induced chemotaxis and calcium flux of human activated highly polarized Th2 cells through CCR8. Wild-type but not Ccr8-deficient activated mouse Th2 cells migrated in response to CCL18. CCL18 and CCR8 were coexpressed in esophageal biopsy tissue from individuals with active eosinophilic esophagitis (EoE) and were present at markedly higher levels compared with esophageal tissue isolated from EoE patients whose disease was in remission or in normal controls. Identifying CCR8 as a chemokine receptor for CCL18 will help clarify the biological role of this highly expressed chemokine in human disease.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service